403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Ozempic-Maker Novo Nordisk Says CEO To Step Down
(MENAFN- The Peninsula)
AFP
Copenhagen: Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said Friday its chief executive was stepping down from his role.
"A search for Lars Fruergaard Jorgensen's successor is ongoing, and an announcement will be made in due course," the company said in a statement, adding that the decision had been a "mutual agreement with the Novo Nordisk board ... in light of the recent market challenges Novo Nordisk has been facing and the development of the company's share price since mid-2024".
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment